{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T08:05:58Z","timestamp":1777363558858,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.medcli.2026.107368","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T01:16:27Z","timestamp":1771636587000},"page":"107368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Persistence of sex differences and stable trends in mortality in patients with mycosis fungoides and S\u00e9zary syndrome in Spain (1983\u20132022)"],"prefix":"10.1016","volume":"166","author":[{"given":"Roc\u00edo C.","family":"Bueno-Molina","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan-Carlos","family":"Hern\u00e1ndez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mercedes","family":"Morillo-And\u00fajar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luc\u00eda","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aurelio","family":"Cayuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9-Juan","family":"Pereyra-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107368_bib0150","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ad.2020.08.003","article-title":"Cutaneous lymphomas \u2013 Part I: mycosis fungoides, S\u00e9zary syndrome, and CD30+ cutaneous lymphoproliferative disorders","volume":"112","author":"Pujol","year":"2021","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.medcli.2026.107368_bib0155","first-page":"386","article-title":"Mycosis fungoides and S\u00e9zary syndrome \u2013 review and outlook","volume":"21","author":"Latzka","year":"2023","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.medcli.2026.107368_bib0160","first-page":"532","article-title":"Evaluation of mortality, prognostic parameters, and treatment efficacy in mycosis fungoides","volume":"22","author":"Porkert","year":"2024","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.medcli.2026.107368_bib0165","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ad.2022.11.010","article-title":"Primary cutaneous lymphoma registry of the Spanish Academy of Dermatology and Venereology (AEDV): data for the first 5 years","volume":"114","author":"Falkenhain-L\u00f3pez","year":"2023","journal-title":"Actas Dermosifiliogr"},{"key":"10.1016\/j.medcli.2026.107368_bib0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.jid.2019.07.712","article-title":"Overall survival in mycosis fungoides: a systematic review and meta-analysis","volume":"140","author":"Mourad","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.medcli.2026.107368_bib0175","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1111\/pde.14811","article-title":"Primary cutaneous lymphomas in children: a prospective study from the Spanish Academy of Dermatology and Venereology (AEDV) Primary Cutaneous Lymphoma Registry","volume":"38","author":"Torre-Castro","year":"2021","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.medcli.2026.107368_bib0180","article-title":"Factors associated with in-hospital mortality in mycosis fungoides patients: a multivariable analysis","volume":"14","author":"King","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.medcli.2026.107368_bib0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2022.104108","article-title":"Recent advances on cutaneous lymphoma epidemiology","volume":"51","author":"Dobos","year":"2022","journal-title":"Presse Med"},{"key":"10.1016\/j.medcli.2026.107368_bib0190","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.3390\/cancers12102921","article-title":"Epidemiology of cutaneous t-cell lymphomas: a systematic review and meta-analysis of 16,953 patients","volume":"12","author":"Dobos","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2026.107368_bib0195","doi-asserted-by":"crossref","first-page":"5669","DOI":"10.3390\/cancers15235669","article-title":"A retrospective chart review of treatment patterns and overall survival among a cohort of patients with relapsed\/refractory mycosis fungoides in France, Germany, Italy, Spain and the United Kingdom","volume":"15","author":"Assaf","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.medcli.2026.107368_bib0200","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1001\/jamaoncol.2022.3236","article-title":"Incidence trends of primary cutaneous T-cell lymphoma in the US from 2000 to 2018: a SEER population data analysis","volume":"8","author":"Cai","year":"2022","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.medcli.2026.107368_bib0205","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/bjd.19644","article-title":"Epidemiological changes in cutaneous lymphomas: an analysis of 8593 patients from the French Cutaneous Lymphoma Registry","volume":"184","author":"Dobos","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.medcli.2026.107368_bib0210","doi-asserted-by":"crossref","first-page":"3550","DOI":"10.1002\/cncr.30758","article-title":"Comprehensive analysis of cutaneous T-cell lymphoma (CTCL) incidence and mortality in Canada reveals changing trends and geographic clustering for this malignancy","volume":"123","author":"Ghazawi","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.medcli.2026.107368_bib0215","doi-asserted-by":"crossref","DOI":"10.1002\/cam4.7056","article-title":"Global burden, risk factors, and trends of non-hodgkin lymphoma: a worldwide analysis of cancer registries","volume":"13","author":"Huang","year":"2024","journal-title":"Cancer Med"},{"key":"10.1016\/j.medcli.2026.107368_bib0220","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1158\/1055-9965.EPI-15-0921","article-title":"Contributions of subtypes of non-Hodgkin lymphoma to mortality trends","volume":"25","author":"Howlader","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.medcli.2026.107368_bib0225","article-title":"Guidelines for accurate and transparent health estimates reporting: the GATHER statement","volume":"13","author":"Stevens","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/j.medcli.2026.107368_bib0230","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jclinepi.2007.11.008","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"61","author":"Von Elm","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.medcli.2026.107368_bib0235","series-title":"Revision of the European Standard Population: REPORT of Eurostat's Task Force","author":"Pace","year":"2013"},{"key":"10.1016\/j.medcli.2026.107368_bib0240","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2105\/AJPH.89.8.1240","article-title":"Twenty-year trends in the reported incidence of mycosis fungoides and associated mortality","volume":"89","author":"Weinstock","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.medcli.2026.107368_bib0245","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/1078-0432.CCR-14-3322","article-title":"The use of transcriptional profiling to improve personalized diagnosis and management of cutaneous T-cell lymphoma (CTCL)","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medcli.2026.107368_bib0250","first-page":"1253","article-title":"Occupational exposures and mycosis fungoides. A European multicentre case\u2013control study (Europe)","volume":"16","author":"Morales-Su\u00e1rez-Varela","year":"2005","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.medcli.2026.107368_bib0255","doi-asserted-by":"crossref","first-page":"522","DOI":"10.6004\/jnccn.2020.0022","article-title":"Primary cutaneous lymphomas, version 2.2020. Featured updates to the NCCN guidelines","volume":"18","author":"Mehta-Shah","year":"2020","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.medcli.2026.107368_bib0260","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3389\/fonc.2019.00300","article-title":"Environmental and other extrinsic risk factors contributing to the pathogenesis of cutaneous T cell lymphoma (CTCL)","volume":"9","author":"Ghazawi","year":"2019","journal-title":"Front Oncol"},{"key":"10.1016\/j.medcli.2026.107368_bib0265","doi-asserted-by":"crossref","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and s\u00e9zary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.medcli.2026.107368_bib0270","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1200\/JCO.2015.61.7142","article-title":"Cutaneous lymphoma international consortium study of outcome in advanced stages of mycosis fungoides and S\u00e9zary syndrome: effect of specific prognostic markers on survival and development of a prognostic model","volume":"33","author":"Scarisbrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.medcli.2026.107368_bib0275","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jdermsci.2009.10.010","article-title":"Prognosis of 100 Japanese patients with mycosis fungoides and S\u00e9zary syndrome","volume":"57","author":"Suzuki","year":"2010","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.medcli.2026.107368_bib0280","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1093\/annonc\/mdx352","article-title":"Global patterns of care in advanced stage mycosis fungoides\/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium","volume":"28","author":"Quaglino","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.medcli.2026.107368_bib0285","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1365-2141.2011.08852.x","article-title":"Evolving insights in the pathogenesis and therapy of cutaneous T-cell lymphoma (mycosis fungoides and Sezary syndrome)","volume":"155","author":"Wong","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.medcli.2026.107368_bib0290","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.clml.2015.02.027","article-title":"Advanced-stage mycosis fungoides and S\u00e9zary syndrome: survival and response to treatment","volume":"15","author":"Alberti-Violetti","year":"2015","journal-title":"Clin Lymphoma Myeloma Leuk"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T14:07:10Z","timestamp":1774620430000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S0025775326000187"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107368","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of sex differences and stable trends in mortality in patients with mycosis fungoides and S\u00e9zary syndrome in Spain (1983\u20132022)","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107368","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107368"}}